Holen Sie sich die Stockscreener-App
34.80
0.37%
-0.13
Handel nachbörslich:
33.52
-1.28
-3.68%
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Key resistance and support levels for Veracyte Inc.July 2025 Earnings & Long-Term Safe Return Strategies - newser.com
What analyst consensus implies for Veracyte Inc. (12V) stockRate Hike & Technical Confirmation Trade Alerts - newser.com
Veracyte, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
How high can Veracyte Inc. stock goInsider Buying & Stock Portfolio Risk Control - newser.com
Veracyte Inc. stock daily chart insights2025 Earnings Impact & Real-Time Volume Analysis Alerts - newser.com
Veracyte Inc Stock Analysis and ForecastPrice Volatility Patterns & Rapid Capital Growth - earlytimes.in
What MACD signals say about Veracyte Inc.Trade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Real time social sentiment graph for Veracyte Inc.Layoff News & Daily Volume Surge Trade Alerts - newser.com
Has Veracyte Inc. formed a bullish divergenceJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Why Veracyte Inc. (12V) stock stays on buy listsJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Veracyte's (VCYT) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Does Veracyte Inc. qualify in momentum factor screeningJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
How supply chain issues affect Veracyte Inc. stockJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Veracyte (NASDAQ:VCYT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
What analysts say about Veracyte Inc 12V stockStock Price Targets & Superior Capital Trading Plans - earlytimes.in
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte (NASDAQ:VCYT) Insider Sells 8,349 Shares - MarketBeat
Is Veracyte Inc a good long term investmentStock Price Forecasts & Options Trading Analysis Tools - earlytimes.in
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Will Veracyte (VCYT) Leverage PAM50 Data to Strengthen Its Position in Precision Oncology? - Sahm
Veracyte (VCYT): Reassessing Valuation After New BALANCE Trial Data Highlights Decipher’s Clinical Impact - Yahoo Finance
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Why Veracyte Inc. (12V) stock could break out in 2025Weekly Trade Review & Reliable Trade Execution Plans - newser.com
Using data tools to time your Veracyte Inc. exitWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Veracyte Inc. (12V) stock compares with top peersEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Can machine learning forecast Veracyte Inc. recoveryQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Veracyte to replace Triumph in S&P SmallCap 600 index - MSN
Insider Sell Alert: John Leite Sells Shares of Veracyte Inc (VCY - GuruFocus
Veracyte started at buy by UBS, MRD platform cited - MSN
Veracyte Inc. stock outlook for YEAR2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Applying sector rotation models to Veracyte Inc.Portfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
AMI Asset Management Corp Sells 8,580 Shares of Veracyte, Inc. $VCYT - MarketBeat
What analysts say about Veracyte Inc stockSector-Based Investing & Minimal Capital Investment - earlytimes.in
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term - Yahoo Finance
0.17%
2.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):